Page last updated: 2024-08-23

tetradecanoylphorbol acetate and Cystadenocarcinoma

tetradecanoylphorbol acetate has been researched along with Cystadenocarcinoma in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hirata, J; Imaizumi, E; Ishii, K; Kikuchi, Y; Kita, T; Kudoh, K; Nagata, I; Tode, T1

Other Studies

1 other study(ies) available for tetradecanoylphorbol acetate and Cystadenocarcinoma

ArticleYear
Modulation of sensitivity of human ovarian cancer cells to cis-diamminedichloroplatinum(II) by 12-O-tetradecanoylphorbol-13-acetate and D,L-buthionine-S,R-sulphoximine.
    International journal of cancer, 1993, Sep-30, Volume: 55, Issue:3

    Topics: Buthionine Sulfoximine; Cell Division; Cisplatin; Cystadenocarcinoma; Drug Resistance; Female; Humans; Methionine Sulfoximine; Ovarian Neoplasms; Protein Kinase C; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured

1993